London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


An outbreak of endophthalmitis after clear corneal phacoemulsification

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Inflammation in Ocular Infections

Session Date/Time: Wednesday 17/09/2014 | 08:00-09:30

Paper Time: 08:06

Venue: Capital Hall A

First Author: : A.Deka INDIA

Co Author(s): :    S. Saikia              

Abstract Details

Purpose:

To report a series of patients with endophthalmitis after uncomplicated phacoemulsification performed by multiple surgeon

Setting:

Bawri Nethralaya

Methods:

Clinical presentation and microbiology analysis of patients who presented with endophthalmitis between September 1st 2012 and March, 2013, were reviewed. Same preoperative and postoperative protocol was followed except preference of intracameral moxifloxacin, which was preferred by one surgeon. Clinical presentations and outcome were compared on the basis of causative organism.

Results:

Seventeen cases were identified with endophthalmitis, presenting 7 to 21 days after uneventful phacoemulsification. All cases were treated initially with a vitreous tap and injection; 9 patients subsequently undergone vitrectomy. Microbiology cultures for 2 patients were positive for staphylococcus epidermidis , 5 cases were positive for burkholderia cebacia, 2 were positive for aspergillus species, mixed infection in 2 cases and no growth/unknown 6 cases. 36% cases were resistance to moxifloxacin and 45% cases were resistance to cefuroxime. In 3 cases vision improved to 20/40 and 11cases achieved vision of 20/40-20/200 after certain intervention. However 3 cases progressed to phthysical.

Conclusions:

Endophthalmitis is rare but difficult to treat. Multiple drugs resistance is alarming. More researches are necessary to understand the course and outcome of the infection.

Financial Interest:

NONE

Back to previous